- Home
- SNTG vs CHEK Comparison
SNTG vs CHEK Comparison
Compare SNTG & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTG
- CHEK
- Stock Information
- Founded
- SNTG 2009
- CHEK 2004
- Country
- SNTG China
- CHEK Israel
- Employees
- SNTG N/A
- CHEK N/A
- Industry
- SNTG Finance: Consumer Services
- CHEK Medical Electronics
- Sector
- SNTG Finance
- CHEK Health Care
- Exchange
- SNTG Nasdaq
- CHEK Nasdaq
- Market Cap
- SNTG 4.8M
- CHEK 3.9M
- IPO Year
- SNTG 2021
- CHEK 2015
- Fundamental
- Price
- SNTG $3.06
- CHEK $2.44
- Analyst Decision
- SNTG
- CHEK
- Analyst Count
- SNTG 0
- CHEK 0
- Target Price
- SNTG N/A
- CHEK N/A
- AVG Volume (30 Days)
- SNTG 4.6M
- CHEK 7.5M
- Earning Date
- SNTG 05-14-2025
- CHEK 11-14-2025
- Dividend Yield
- SNTG N/A
- CHEK N/A
- EPS Growth
- SNTG N/A
- CHEK N/A
- EPS
- SNTG N/A
- CHEK N/A
- Revenue
- SNTG $107,507.00
- CHEK N/A
- Revenue This Year
- SNTG N/A
- CHEK N/A
- Revenue Next Year
- SNTG N/A
- CHEK N/A
- P/E Ratio
- SNTG N/A
- CHEK N/A
- Revenue Growth
- SNTG N/A
- CHEK N/A
- 52 Week Low
- SNTG $1.43
- CHEK $0.56
- 52 Week High
- SNTG $12.70
- CHEK $3.13
- Technical
- Relative Strength Index (RSI)
- SNTG 52.40
- CHEK 75.97
- Support Level
- SNTG N/A
- CHEK N/A
- Resistance Level
- SNTG $6.90
- CHEK $0.77
- Average True Range (ATR)
- SNTG 1.58
- CHEK 0.12
- MACD
- SNTG -0.10
- CHEK 0.09
- Stochastic Oscillator
- SNTG 23.54
- CHEK 84.03
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.